| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/11/2011 | CA2788766A1 Treatment of respiratory disorders |
| 08/11/2011 | CA2788736A1 Polyanionic multivalent macromolecules for intracellular targeting of proliferation and protein synthesis |
| 08/11/2011 | CA2788675A1 Carrier composition |
| 08/11/2011 | CA2788663A1 Taxane-and taxoid-protein compositions |
| 08/11/2011 | CA2788588A1 A method for altering the flavor of a food product |
| 08/11/2011 | CA2788347A1 Disruptive polymer micelle composition |
| 08/11/2011 | CA2787725A1 Liposomes containing prostaglandin e1 (pge1), formulations containing them and their use |
| 08/11/2011 | CA2782444A1 Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof |
| 08/10/2011 | EP2354163A2 Conjugates of duocarmycin and anti-CD70 or anti-PSMA antibodies |
| 08/10/2011 | EP2354149A1 Molecules with extended half-lives, compositions and uses thereof |
| 08/10/2011 | EP2353611A2 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
| 08/10/2011 | EP2353587A2 Antimicrobial compositions and methods |
| 08/10/2011 | EP2353586A1 Film-form preparation |
| 08/10/2011 | EP2353547A1 Agent for regenerating tympanic membrane or external auditory canal |
| 08/10/2011 | EP2352526A1 Treating cancer stem cells using targeted cargo proteins |
| 08/10/2011 | EP2352525A1 Somatostatin analogues |
| 08/10/2011 | EP2352522A1 Bispecific intracellular delivery vehicles |
| 08/10/2011 | EP2352509A1 Hla-g proteins and pharmaceutical uses thereof |
| 08/10/2011 | EP2352491A2 Plant-based granules |
| 08/10/2011 | EP1973524B1 Concentrated liquid thyroid hormone composition |
| 08/10/2011 | EP1747277B1 Gene delivery to neuronal cells |
| 08/10/2011 | EP1656126B1 Preparing method for controlled released type tablet comprising tamsulosin hcl and the tablet produced thereof |
| 08/10/2011 | EP1633800B1 Polyamino acids functionalised with at least one hydrophobic group and applications thereof particularly therapeutic applications |
| 08/10/2011 | EP1594513B1 Carbohydrate conjugates to prevent abuse of controlled substances |
| 08/10/2011 | EP1496873B2 Chewable soft capsule |
| 08/10/2011 | EP1461079B1 Human immunodeficiency virus envelope clycoprotein mutants and uses thereof |
| 08/10/2011 | EP1437975B1 Optically-absorbing nanoparticles for enhanced tissue repair |
| 08/10/2011 | EP1430157B1 RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS C VIRUS (HCV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/10/2011 | EP1341527B1 Pharmaceutical preparation comprising an active dispersed on a matrix |
| 08/10/2011 | EP1212349B1 Recombinant subunit vaccine |
| 08/10/2011 | CN1984924B Methods for increasing conjugation of protein and polyethylene glycol (PEG) |
| 08/10/2011 | CN1895324B Jinganmin dispersing tablets and preparation thereof |
| 08/10/2011 | CN1853627B Cyclodextrin of bibenziisosehenazole ethane or cyclodextrin derivative inclusion compound, and preparation and use thereof |
| 08/10/2011 | CN1529588B Pharmaceutical formulation |
| 08/10/2011 | CN102149411A Method of acylating a peptide or protein |
| 08/10/2011 | CN102149410A Composite organic compound powder for medical use, method for producing same and suspension of same |
| 08/10/2011 | CN102149409A Process for preparing microparticles |
| 08/10/2011 | CN102149408A Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens |
| 08/10/2011 | CN102149379A Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 08/10/2011 | CN102149374A Orally administrable formulation containing branched chain amino acid |
| 08/10/2011 | CN102149371A Chelating amphiphilic polymers |
| 08/10/2011 | CN102149368A Improvements in the absorption of therapeutic agents across mucosal membranes or the skin |
| 08/10/2011 | CN102146200A Temperature-sensitive hydrogel based on chemical cross-linking gel granules and preparation method of temperature-sensitive hydrogel |
| 08/10/2011 | CN102145183A Method for preparing nanogate carbon suspension |
| 08/10/2011 | CN102145178A PEG interleukin 15 |
| 08/10/2011 | CN102145177A Method for preparing folate molecular targeted magnetic nanometer medicine carrier and targeting gene medicine |
| 08/10/2011 | CN102145176A Targeting protein-polyethylene glycol-anticancer medicament junctional complex |
| 08/10/2011 | CN102145175A Sorafenib tosylate-hydroxypropyl-beta-cyclodextrin clathrate compound and preparation method thereof |
| 08/10/2011 | CN102145174A Chondroitin sulfate nano-selenium and preparation method thereof |
| 08/10/2011 | CN102145173A Human serum albumin complex hydrophobically modified pullulan nanoparticles and preparation method thereof |
| 08/10/2011 | CN102145172A Composition for improving absorbance of aminoglycoside drug |
| 08/10/2011 | CN102145171A Method for preparing hydroxyapatite and hydrotalcite composite material with eggshell as raw material |
| 08/10/2011 | CN102145164A IAPP (Islet Amyloid Polypeptide) analog injection with better stability |
| 08/10/2011 | CN102145162A Injection of medicine for treating premature delivery |
| 08/10/2011 | CN102145160A Controlled-release implanting preparation used for injecting LHRH (luteinizing hormone releasing hormone) antagonist |
| 08/10/2011 | CN102145084A Wolfberry seed oil self-microemulsifying nano composition and preparation method thereof |
| 08/10/2011 | CN102145029A Lycopene-containing tablets and preparation method thereof |
| 08/10/2011 | CN102145017A Method for improving hot-melt wall sticking in spray drying process of traditional Chinese medicinal extracting solution |
| 08/10/2011 | CN102145008A Dirithromycin medicinal composition and preparation method thereof |
| 08/10/2011 | CN102145001A Stable aztreonam composition and preparation method thereof |
| 08/10/2011 | CN102144991A Composition containing selegiline and transdermal patch containing composition |
| 08/10/2011 | CN102144989A Preparation method of hydrogel cataplasm and prepared cataplasm with effect of relieving swelling and pains |
| 08/10/2011 | CN102144988A Chitosan cervix uteri anti-microbial membrane and preparation method thereof |
| 08/10/2011 | CN102144987A Metoprolol oral pulsatile tablet and preparation method and application of metoprolol oral pulsatile tablet |
| 08/10/2011 | CN102144986A Potassium chloride cyclopenthiazide sustained release tablet and preparation method thereof |
| 08/10/2011 | CN102144985A Potassium chloride elementary osmotic pump controlled release tablet and preparation method thereof |
| 08/10/2011 | CN102144984A Easy-dissolution lamivudine tablet and preparation method thereof |
| 08/10/2011 | CN102144983A Entecavir dispersible tablets and preparation method thereof |
| 08/10/2011 | CN102144982A Minodronate tablets and preparation method thereof |
| 08/10/2011 | CN102144981A Gemcitabine hydrochloride lyophilized powder injection and preparation method thereof |
| 08/10/2011 | CN102144979A frozen powder preparation for injection of L-gossypol or acetate of L-gossypol for treatment of tumor |
| 08/10/2011 | CN102144978A Acetylcysteine granule and preparation technology thereof |
| 08/10/2011 | CN102144977A Preparation method of growth hormone nanoparticles with biological activity |
| 08/10/2011 | CN102144975A Cefprozil suspension pharmaceutical composition |
| 08/10/2011 | CN102144974A Liposome preparation for anticoagulant thrombolytic difunctional fusion protein and preparation method thereof |
| 08/10/2011 | CN102144973A Prescription composition of optimized siRNA cation liposome |
| 08/10/2011 | CN102144972A Podophyllotoxin ethosomes and preparation methods thereof |
| 08/10/2011 | CN102144971A Fasudil-containing oral spray or aerosol |
| 08/10/2011 | CN102144970A Alprostadil lipid nanosphere injection and preparation method thereof |
| 08/10/2011 | CN102144969A Method for preparing etoposide nanometer suspension freeze-drying preparation |
| 08/10/2011 | CN102144968A Oral suspension of liposome-encapsulated insulin lyophilized preparation and preparation process thereof |
| 08/10/2011 | CN102144966A Preparation method of clindamycin phosphate injection |
| 08/10/2011 | CN102144965A More-stable carbetocin acetate injection |
| 08/10/2011 | CN102144964A Stable and safe edaravone injecta |
| 08/10/2011 | CN102144963A Citicoline sodium glucose injecta and preparation process thereof |
| 08/10/2011 | CN102144962A Powdered osletamirvir phosphate medicinal composition |
| 08/10/2011 | CN101824118B Porous polymer nanoparticles and preparation method thereof |
| 08/10/2011 | CN101717515B Copolymer of fibroin and poly L-lactic acid and preparation method and application thereof |
| 08/10/2011 | CN101708337B Preparation method of human serum albumin nano granules coated with oxaliplatin |
| 08/10/2011 | CN101703471B Improved method for preparing liposome by using ammonium sulfate gradient method |
| 08/10/2011 | CN101700270B Traditional Chinese medicine composition used for neurasthenia and preparation method and quality control method thereof |
| 08/10/2011 | CN101700227B Matrine colon targeted adhesive pellet and preparation method thereof |
| 08/10/2011 | CN101695482B Glipizide orally disintegrating tablet and preparation process thereof |
| 08/10/2011 | CN101664556B Lactose-polyvidone-crospolyvidone premixed agent and preparation method thereof |
| 08/10/2011 | CN101664427B Method for preparing traditional Chinese medicine preparation containing Ainsliaea fragrans extracts |
| 08/10/2011 | CN101543509B Ophthalmic gel containing chondroitin sulfate and method for preparing same |
| 08/10/2011 | CN101500614B Method for making polyethylene glycol carbonates |
| 08/10/2011 | CN101461837B Method for preparing total flavones nano aqueous solution of astragalus |
| 08/10/2011 | CN101411864B Thymopentin dry powder formulation and preparation method thereof |
| 08/10/2011 | CN101401849B Uses of tea polyphenol traditional Chinese medicine compound in preparing medicament for reducing blood fat and blood sugar |